WASHINGTON (MedPage Today) — Decitabine (Dacogen), a hypomethylating agent, does not appear to improve mortality in older patients with acute myelogenous leukemia, FDA reviewers concluded.
Filed under: General Health News
(MedPage Today) — Rotational head injuries in fighting sports can be minimized if participants wear padded boxing gloves and headgear rather lighter protective gear or no protection at all, a laboratory study suggested.
Filed under: General Health News
(MedPage Today) — The FDA warned today that use of proton pump inhibitors — including popular brands such as Nexium, Prilosec, and Prevacid — may increase the risk of Clostridium difficile-associated diarrhea.
Filed under: General Health News
(MedPage Today) — Just 10 types of food account for nearly half of the nation’s excessive sodium intake, government researchers found.
Filed under: General Health News
Researchers at Zucker Hillside Hospital’s Recognition and Prevention (RAP) Program who have worked with teenagers at risk for serious mental illness for the past decade are now studying the effectiveness of Omega 3 fatty acids (fish oil) for treating psychiatric symptoms.
Filed under: Pharmacy News
Genzyme, a Sanofi company, announced today four-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate.
Filed under: Pharmacy News
Exemestane, a drug used in the prevention of breast cancer in postmenopausal women, has a negative effect on bone density and structure in these women, despite calcium and vitamin D supplements.
Filed under: Pharmacy News
The Center for LAM Research and Clinical Care at Brigham and Women’s Hospital (BWH) has been awarded a $1 million plus, four-year grant from the U.S. Department of Defense Office of the Congressionally Directed Medical Research Programs to fund their work on lymphangioleiomyomatosis.
Filed under: Pharmacy News
Researchers at the Rothman Institute at Jefferson examined data on patients being treated for lumbar stenosis and the degenerative spine condition spondylolisthesis and found that patients who received epidural steroid injections (ESI) had a higher rate of crossover to surgery and fared worse in physical health and bodily pain versus those who did not receive ESI, dispelling their pre-study hypothesis.
Filed under: Pharmacy News
Patients taking antidepressants up to three years prior to undergoing a total hip replacement (THR) were more likely to report greater pain before and after surgery and less satisfaction with their procedure, according to new research presented today at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
Filed under: Pharmacy News
